Table 1.

Patient characteristics and detection results.

	All (%) n = 128 (100)	Group 1 (%) HIV-infected patients n = 50 (39.1)	Group 2 (%) hematological malignancy n = 51 (39.8)	Group 3 (%) immunosuppressive treatment n = 27 (21.1)
Age years
Median	49.5	41.5	55.0	57.0
Range	18–86	18–67	20–86	25–81
Sex male (%)	97 (75.8)	43 (86.0)	33 (64.7)	21 (77.7)
Pathogen (%)
Pneumocystis jirovecii	26 (20.3)	17 (34.0)	5 (9.8)	4 (14.8)
RSV	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
HBoV	1 (0.8)	0 (0.0)	1 (2.0)	0 (0.0)
HMPV	1 (0.8)	0 (0.0)	1 (2.0)	0 (0.0)
Influenza A	2 (1.3)	1 (2.0)	0 (0.0)	1 (3.7)
Influenza B	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Coronavirus	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
CMV	1 (0.8)	0 (0.0)	1 (2)	0 (0.0)
Bacteria	10 (7.8)	4 (8.0)	5 (9.8)	1 (3.7)
Fungi	5 (3.9)	0 (0.0)	4 (7.8)	1 (3.7)
Copathogen	1 (0.8)	1 (2.0)	0 (0.0)	0 (0.0)
No pathogen	82 (64.1)	29 (58.0)	32 (62.7)	21 (77.7)